FDA Approves Daratumumab Hyaluronidase‑Fihj Quadruplet Regimen for Newly Diagnosed Multiple Myeloma

February 9, 2026 Dr. Michael Lee – Health Editor Health

Here are the ⁤two URLs provided in the‌ text:

  1. https://www.fda.gov/drugs/resources-details-approved-drugs/fda-approves-daratumumab-and-hyaluronidase-fihj-multiple-myeloma
  2. https://multiplemyelomahub.com/medical-information/daratumumab-approved-by-fda-for-frontline-use